Roic.ailogo
Powered by AI
US stock · Healthcare sector · Diagnostics & Research
Company Logo

Syneos Health, Inc.

SYNHNASDAQ

34.33

USD
-0.61
(-1.75%)
Pre Market
14.76P/E
9Forward P/E
0.70P/E to S&P500
3.544BMarket CAP
- -Div Yield
SummaryFinancialsTranscriptsMonitoringClassic View
Upcoming Earnings
27 Apr-1 May
Shares Short
3/15/23
3.43M
Short % of Float
3.33%
Short % of Shares Outs.
3.32%
% Held by Insiders
0.71%
% Held by Institutions
104.40%
Beta
1.66
PEG Ratio
38.74
52w. high/low
85.45/22.89
Avg. Daily Volume
1.76M
Return %
Stock
S&P 500
1 year
(55.32)
(9.05)
3 years
(29.84)
50.26
5 years
(16.01)
38.50
Scale: |
High
Low
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
26.85
19.61
51.69
22.17
57.11
34.19
61.10
33.60
53.95
31.10
59.85
36.56
74.25
30.02
104.18
66.02
102.67
22.89
43.35
33.14
Currency: USD
- -
- -
- -
- -
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Revenue per share
- -
- -
- -
- -
12.64
16.74
16.55
22.12
24.17
29.81
35.67
42.45
45.13
42.39
50.19
52.37
Earnings per share
- -
- -
- -
- -
(1.15)
(1.14)
(0.69)
(0.44)
2.02
2.08
(1.85)
0.23
1.27
1.85
2.26
2.59
FCF per share
- -
- -
- -
- -
(0.45)
0.64
0.33
1.99
3.17
1.44
2.06
2.41
2.46
3.60
3.79
3.24
Dividends per share
- -
- -
- -
- -
0.09
0.01
0.01
0.01
- -
- -
- -
- -
- -
- -
- -
- -
CAPEX per share
- -
- -
- -
- -
0.09
0.18
0.29
0.48
0.36
0.58
0.59
0.53
0.62
0.48
0.55
0.91
Book Value per sh.
- -
- -
- -
- -
- -
6.10
4.59
7.36
3.76
5.58
40.35
27.62
29.24
31.12
32.85
33.94
Comm.Shares outs.
- -
- -
- -
- -
52
52
60
53
58
54
75
103
104
104
104
103
Avg. annual P/E ratio
- -
- -
- -
- -
- -
- -
- -
(52.9)
18.7
21.3
(27.4)
188.4
38.8
31.6
38.1
25.5
P/E to S&P500
- -
- -
- -
- -
- -
- -
- -
(2.9)
0.9
1.0
(1.2)
7.5
1.6
0.8
1.3
1.2
Avg. annual div. yield
- -
- -
- -
- -
- -
- -
- -
0.0%
- -
- -
- -
- -
- -
- -
- -
- -
Revenue (m)
- -
- -
- -
- -
656
869
995
1,179
1,399
1,611
2,672
4,390
4,676
4,416
5,213
5,393
Operating margin
- -
- -
- -
- -
(6.1)%
(4.3)%
3.2%
5.4%
10.9%
9.6%
(1.1)%
3.6%
5.1%
6.6%
7.5%
8.5%
Depreciation (m)
- -
- -
- -
- -
64
79
58
55
56
59
180
274
242
222
236
247
Net profit (m)
- -
- -
- -
- -
(60)
(59)
(42)
(23)
117
113
(138)
24
131
193
235
266
Income tax rate
- -
- -
- -
- -
36.8%
37.7%
(35.4)%
16.8%
10.6%
16.0%
(23.8)%
57.6%
(29.1)%
5.3%
25.5%
15.3%
Net profit margin
- -
- -
- -
- -
(9.1)%
(6.8)%
(4.2)%
(2.0)%
8.4%
7.0%
(5.2)%
0.6%
2.8%
4.4%
4.5%
4.9%
Working capital (m)
- -
- -
- -
- -
- -
44
58
47
(53)
56
263
(11)
46
161
112
219
Long-term debt (m)
- -
- -
- -
- -
- -
588
587
415
472
486
2,966
2,764
2,806
3,155
3,016
2,831
Equity (m)
- -
- -
- -
- -
- -
317
276
392
217
301
3,023
2,856
3,030
3,242
3,413
3,495
ROIC
- -
- -
- -
- -
- -
(2.1)%
4.5%
2.4%
17.8%
14.9%
(1.0)%
1.4%
5.0%
4.3%
4.5%
5.2%
Return on capital
- -
- -
- -
- -
- -
(2.6)%
2.4%
2.0%
12.1%
11.3%
(0.7)%
2.6%
3.1%
3.7%
4.8%
4.8%
Return on equity
- -
- -
- -
- -
- -
(18.7)%
(15.0)%
(6.0)%
53.8%
37.4%
(4.6)%
0.9%
4.3%
5.9%
6.9%
7.6%
Plowback ratio
- -
- -
- -
- -
107.6%
100.8%
101.2%
101.6%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
Div.&Repurch./FCF
- -
- -
- -
- -
- -
- -
- -
- -
156.0%
82.7%
- -
30.1%
22.3%
18.7%
29.9%
45.0%
Capital Structure
16 Feb · 2023 | Q4
All numbers in millions
Total liabilities
$ 4,704
Total assets
$ 8,199
Long-term debt
$ 2,831
Cash and equiv.
$ 112
Goodwill
$ 4,898
Retained earnings
$ 168
Common stock
103
Enterprise Value
$ 6,263
Working Capital
Currency: USD, in millions
2020
2021
2022
Cash & Investments
272
106
112
Receivables
1,345
1,525
1,645
Inventory
- -
- -
- -
Other
121
(31)
27
Current assets
1,738
1,766
1,944
Acc. Payable
114
108
119
Debt due
60
64
68
Other
1,404
1,483
1,538
Current liabilities
1,577
1,654
1,725
Annual growth rates
(avg. rate of change)
1 year
5 years
10 years
Revenue
3.46%
5.61%
22.77%
Cash flow
(15.23)%
9.84%
72.88%
Earnings
13.48%
130.67%
(51.53)%
Dividends
- -
- -
- -
Book value
2.42%
5.19%
105.99%
Insider Trading
Type
Shares
Date
Brooks Michael Lee
Award
2,083
02/23/23
Brooks Michael Lee
Award
738
02/23/23
Tucat Christian
InKind
1,051
02/23/23
Tucat Christian
Award
563
02/23/23
Tucat Christian
Award
547
02/23/23
Quarterly Revenue
Currency: USD, in millions
Year
1Q
2Q
3Q
4Q
Total
2020
1,163
1,013
1,099
1,140
4,416
2021
1,209
1,283
1,348
1,373
5,213
2022
1,336
1,361
1,336
1,360
5,393
Earnings per share
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
0.32
0.04
0.61
0.88
1.85
2021
0.37
0.40
0.75
0.73
2.26
2022
0.45
0.75
0.85
0.54
2.59
Quarterly dividends paid
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
Company Description
Sector:
Healthcare
Industry:
Diagnostics & Research
CEO:
Ms. Michelle Keefe
Full-time employees:
26,751
City:
Morrisville
Address:
1030 Sync Street
IPO:
Nov 7, 2014
CIK:
0001610950
Website:
syneoshealth.com
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. This segment also provides individual services, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health, clinical trial diversity, biometric, and regulatory affair services. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication services; and consulting services to the pharmaceutical, biotechnology, and healthcare industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.